Medicare Reverses Denial Of Costly Treatment For Hepatitis C Patient

Walter Bianco, an Arizona man denied access to new drugs to cure his hepatitis C infection, will get the costly medications after all.
After Kaiser Health News and NPR described his plight in a story that aired Monday, federal Medicare officials said they would look into the case. Bianco’s appeal of an earlier denial had been rejected by WellCare, a private insurer that contracts with the federal program to provide drug coverage. The insurer rejected coverage saying the combined use of the costly new drugs has not yet been approved by the Food and Drug Administration — even though two doctors’ groups had recommended the protocol in cases like Bianco’s. Washington Post (05/16/14)